This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: University of Utah Research Foundation, Ballard Spahr LLP. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: Guy A Zimmerman: Innovator in Inflammatory Disorder Treatments
Introduction
Guy A Zimmerman is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical treatments, particularly in the area of inflammatory disorders. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
Zimmerman's latest patents focus on methods for the treatment and prophylaxis against inflammatory disorders. One of his key inventions is an isolated and purified peptide known as neonatal NET-inhibitory Factor (nNIF). This invention includes methods that involve administering NET-inhibitory peptides (NIPs) to individuals suffering from inflammatory disorders. Additionally, he has developed methods for the treatment of cancer, including the inhibition of metastasis in patients. His work with nNIF and nNIF-related peptides provides innovative approaches to managing these serious health conditions.
Career Highlights
Throughout his career, Guy A Zimmerman has worked with reputable organizations such as the University of Utah Research Foundation and Ballard Spahr LLP. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Zimmerman has collaborated with notable colleagues, including Andrew S Weyrich and Christian Con Yost. These partnerships have further enriched his research and development efforts in the field of medical treatments.
Conclusion
Guy A Zimmerman stands out as an influential inventor whose work in inflammatory disorder treatments and cancer therapies showcases his dedication to improving health outcomes. His innovative patents and collaborations reflect his commitment to advancing medical science.
